Artemis Therapeutics Inc.

ATMS · OTC
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Activities
Net Income-$1,355-$167-$121-$121
Dep. & Amort.$16$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$247$16$14$17
Change in WC$694$78$106-$4
Other Non-Cash$8$0$0$0
Operating Cash Flow-$390-$73-$1-$108
Investing Activities
PP&E Inv.-$26$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$26$0$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$73$0$103
Financing Cash Flow$0$73$0$103
Forex Effect$0$0$0$0
Net Chg. in Cash-$416$0-$1-$5
Supplemental Information
Beg. Cash$471$1$2$7
End Cash$55$1$1$2
Free Cash Flow-$416-$73-$1-$108